3',5'-difluoro-3-(2,3-dimethylphenyl)propiophenone, 97.0%, 1g

[2-(2-bromophenoxy)ethyl]dimethylamine, 95.0%, 1g

(R)-2-(2-(Diphenylphosphino)phenyl)-4-isopropyl-4,5-dihydrooxazole, 95.0%, 1g

3-Fluoro-2-(pyrimidin-2-yl)benzoic acid, 97%, 100mg

[1,4-Bis(diphenylphosphino)butane]palladium(II) Dichloride>96.0%(T)1g

1-Chlorododecane, 98%, 1kg

bScope BS.1152-EPLPH for phase contrast. Biocular with HWF 10x/20 mm eyepieces and Quadruple revolver E-plan Phase 10/20/S40 S100x

tert-Butyl 3-(trifluoromethyl)-4,5-dihydro-1H-pyrazolo[3,4-c]pyridine-6(7H)-carboxylate, 95.0%, 10g

3-Chloro-4-((6-methylpyridin-3-yl)oxy)aniline, 95%, 1g

1-(4-Hydroxy-phenyl)-5-oxo-pyrrolidine-3-carboxylic acid, 95.0%, 1g

1-(2-Chloroethyl)piperidine, 97.0%, 1g

(S)-Ethyl 3-(3-bromophenyl)-2-((tert-butoxycarbonyl)amino)propanoate, 95%, 10g

1-Bromo-4-chloro-2-fluorobenzene, 97.0%, 25g